This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ulesfia

Concordia Healthcare Corp.

Drug Names(s): Benzyl alcohol lotion 5%, Ulesfia Lotion

Description: Ulesfia is the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects.

Deal Structure: In May 2013, Shionogi entered into anagreement with Concordia Pharmaceuticals (CPI), a wholly owned subsidiary of ConcordiaHealthcare, by which CPI acquired the rights to three Shionogi products, Kapvay, Orapred ODT,and Orapred OS, and exclusively licensed the rights to another product, Ulesfia. Shionogi will also provide transition services to CPI as part of this agreement.

Partners: Shionogi & Co. Ltd.


Ulesfia News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug